10-K
Annual Report
ACTUATE THERAPEUTICS, INC.
ACTU
NASDAQ
CIK: 1652935
File #: 001-42139
Balance Sheet
31 line items · 2 periods
XBRL
| Item | Dec 31, 2025 | Dec 31, 2024 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 13,159,423 | 8,641,622 |
Other Non-Operating Current Assets | 483,996 | 566,278 |
Total current assets | 13,643,419 | 9,207,900 |
Other Non-Operating Non-Current Assets | 392,491 | 110,548 |
Total assets | 14,035,910 | 9,318,448 |
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
Current liabilities: | ||
Accounts Payable | 1,524,190 | 1,921,189 |
Other Non-Operating Current Liabilities | 3,567,404 | 5,921,908 |
Other Current Liabilities | 588,304 | 888,449 |
Other Non-Operating Current Liabilities | 27,018 | 70,957 |
UIC License Agreement | — | 70,957 |
Total current liabilities | 5,706,916 | 8,802,503 |
Long term liabilities: | ||
Accrued interest, less current portion | 0 | 6,768 |
UIC License Agreement | — | 6,768 |
License payable | 404,991 | 404,991 |
Total long-term liabilities | 404,991 | 411,759 |
Total liabilities | 6,111,907 | 9,214,262 |
Stockholders’ equity: | ||
Preferred Stock | 0 | 0 |
Total Stockholders' Equity | 23 | 20 |
Total Stockholders' Equity | 162,531,681 | 132,484,015 |
Total Stockholders' Equity | (154,607,701) | (132,379,849) |
Total stockholders’ equity | 7,924,003 | 104,186 |
Common Stock | 23 | 20 |
Additional Paid-in Capital | 162,531,681 | 132,484,015 |
Retained Earnings | (154,607,701) | (132,379,849) |
Total liabilities and stockholders’ equity | 14,035,910 | 9,318,448 |